STOCK TITAN
  1. Home
  2. Sec-filings
  3. HIMS
  4. [Form 4] Hims & Hers Health, Inc. Insider Trading Activity

[Form 4] Hims & Hers Health, Inc. Insider Trading Activity

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4
Insider Chi Michael
Role Chief Commercial Officer
Sold 26,600 shs ($1.78M)
Approx. gross sale proceeds $1.78M
Approx. exercise cost $190K
Approx. pre-tax spread $1.59M
Type Security Shares Price Value
Exercise Stock Option (right to buy) 250 $0.00 $0.00
Exercise Class A Common Stock 250 $11.53 $3K
Sale Class A Common Stock 250 $64.44 $16K
Exercise Stock Option (right to buy) 3,600 $0.00 $0.00
Exercise Stock Option (right to buy) 14,700 $0.00 $0.00
Exercise Stock Option (right to buy) 6,300 $0.00 $0.00
Exercise Stock Option (right to buy) 1,750 $0.00 $0.00
Exercise Class A Common Stock 3,600 $13.90 $50K
Exercise Class A Common Stock 14,700 $5.01 $74K
Exercise Class A Common Stock 6,300 $6.82 $43K
Exercise Class A Common Stock 1,750 $11.53 $20K
Sale Class A Common Stock 26,350 $67.00 $1.77M
Holdings After Transaction: Stock Option (right to buy) — 351,710 shares (Direct); Class A Common Stock — 278,654 shares (Direct)
Footnotes (5)
  1. F1. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 4, 2025 by the Reporting Person.
  2. F2. The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the options vesting on April 19, 2022 and the remaining 75% of the options vesting monthly thereafter.
  3. F3. The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on March 24, 2022, and 1/48th of the options vesting monthly thereafter.
  4. F4. The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on September 10, 2022, and 1/48th of the options vesting monthly thereafter.
  5. F5. The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Chi Michael
(Last) (First) (Middle)
2269 CHESTNUT STREET, #523
(Street)
SAN FRANCISCO CA 94123
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Commercial Officer
3. Date of Earliest Transaction (Month/Day/Year)
07/31/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 07/31/2025 M(1) 3,600 A $13.9 282,254 D
Class A Common Stock 07/31/2025 M(1) 14,700 A $5.01 296,954 D
Class A Common Stock 07/31/2025 M(1) 6,300 A $6.82 303,254 D
Class A Common Stock 07/31/2025 M(1) 1,750 A $11.53 305,004 D
Class A Common Stock 07/31/2025 S(1) 26,350 D $67 278,654 D
Class A Common Stock 08/01/2025 M(1) 250 A $11.53 278,904 D
Class A Common Stock 08/01/2025 S(1) 250 D $64.44 278,654 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $13.9 07/31/2025 M(1) 3,600 (2) 05/27/2031 Class A Common Stock 3,600 $0 7,800 D
Stock Option (right to buy) $5.01 07/31/2025 M(1) 14,700 (3) 02/24/2032 Class A Common Stock 14,700 $0 178,242 D
Stock Option (right to buy) $6.82 07/31/2025 M(1) 6,300 (4) 08/10/2032 Class A Common Stock 6,300 $0 118,062 D
Stock Option (right to buy) $11.53 07/31/2025 M(1) 1,750 (5) 03/01/2033 Class A Common Stock 1,750 $0 47,856 D
Stock Option (right to buy) $11.53 08/01/2025 M(1) 250 (5) 03/01/2033 Class A Common Stock 250 $0 47,606 D
Explanation of Responses:
1. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 4, 2025 by the Reporting Person.
2. The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the options vesting on April 19, 2022 and the remaining 75% of the options vesting monthly thereafter.
3. The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on March 24, 2022, and 1/48th of the options vesting monthly thereafter.
4. The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on September 10, 2022, and 1/48th of the options vesting monthly thereafter.
5. The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023.
Remarks:
/s/ Alexandra Cotter Wilkins, Attorney-in-Fact 08/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR